| 产品名称: | NCI-H1876 H1876 |
|---|---|
| 商品货号: | TS211320 |
| Organism: | Homo sapiens, human |
| Tissue: | lung; derived from metastatic site: lymph node |
| Product Format: | frozen |
| Morphology: | epithelial |
| Culture Properties: | adherent |
| Biosafety Level: | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease: | stage E, carcinoma; classic small cell lung cancer |
| Age: | 59 years |
| Gender: | male |
| Ethnicity: | Caucasian |
| Storage Conditions: | liquid nitrogen vapor phase |
| Derivation: | The line was established in April 1988. |
| Clinical Data: | The patient was a smoker. male Caucasian 59 years |
| Complete Growth Medium: | HITES medium supplemented with 5% fetal bovine serum
|
| Subculturing: | Volumes used in this protocol are for 75 cm2 flask; proportionally reduce or increase amount of dissociation medium for culture vessels of other sizes.
Subcultivation Ratio: 1:3 to 1:6. Medium Renewal: Two times weekly. |
| Cryopreservation: | Culture medium with an additional 5% fetal bovine serum, 95%; DMSO, 5% |
| Culture Conditions: | Temperature: 37°C |
| STR Profile: | Amelogenin: X,Y CSF1PO: 11 D13S317: 12 D16S539: 12 D5S818: 11 D7S820: 10,12 THO1: 6 TPOX: 8,9 vWA: 17 |
| Name of Depositor: | AF Gazdar, JD Minna |
| Deposited As: | Homo sapiens |
| Year of Origin: | 1988 |
| References: | NCI-Navy Medical Oncology Branch Cell Line Supplement. J. Cell. Biochem. suppl. 24: 1996. |